Antibodies News and Research

RSS

How SARS-CoV-2 Omicron subvariants have evolved to evade host T-cell immunity

Researchers investigate whether SARS-CoV-2 and its variants have evolved to evade CD8+ T cell-mediated immunity.

15 Apr 2023

Antibody response to SARS-CoV-2 is stronger and more durable in infants and young children

Researchers evaluated humoral responses to severe acute respiratory syndrome coronavirus 2 in infants.

15 Apr 2023

Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

Researchers developed a novel intranasal vaccine candidate for coronavirus disease 2019 (COVID-19).

14 Apr 2023

Study finds no association between maternal SARS-CoV-2 infection and infant neurodevelopment

Researchers assessed whether exposure to SARS-CoV-2 infections during pregnancy impacted infant neurodevelopment.

13 Apr 2023

B cells use mechanical force to pull antigen molecules off other cells

Most cells evolve slowly, accumulating incremental changes that better suit their environments. Immune cells, because they must adapt rapidly to counter new threats, evolve much more quickly.

13 Apr 2023

AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice

The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make the vaccine less effective over time.

13 Apr 2023

Using an implantable nanofluidic device to tame pancreatic cancer

Houston Methodist nanomedicine researchers have found a way to tame pancreatic cancer - one of the most aggressive and difficult to treat cancers - by delivering immunotherapy directly into the tumor with a device that is smaller than a grain of rice.

13 Apr 2023

MHRA research evaluates two different approaches to cancer therapies

The report 'Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue', published in the PLOS ONE journal, highlights MHRA research which showed that genetic engineering of antibodies used to activate and support the immune system against cancer leads to improvements in their reliability and effectiveness.

13 Apr 2023

New tool provides insight into the developmental history of certain immune cells

A new tool that can uncover the developmental history of certain immune cells is now freely available worldwide. The tool provides insights into the stages that immune cells go through in a healthy individual and how this can be impacted in disease.

13 Apr 2023

Award-winning project uses INTEGRA pipettes for success in international genetic engineering competition

Students from the University of Groningen, Netherlands, enjoyed gold medal success at last year’s iGEM competition.

From INTEGRA Biosciences 13 Apr 2023

The virological characteristics of XBB.1.16

Researchers perform extensive multiscale investigations to explore virological characteristics of the SARS-CoV-2 Omicron XBB subvariant, XBB.1.16.

12 Apr 2023

The identification of vaccinee-derived antibodies with broad-spectrum Omicron neutralization activity

Reported the identification of a panel of vaccinee-derived antibodies with broad-spectrum neutralization activity.

12 Apr 2023

New organoid platform could make vaccine screening quicker and greatly reduce animal testing

Developing and testing new treatments or vaccines for humans almost always requires animal trials, but these experiments can sometimes take years to complete and can raise ethical concerns about the animals' treatment.

12 Apr 2023

SARS-CoV-2 infection among infants born to maternal COVID-19 cases during Omicron variant predominance

Researchers assessed the incidence rate of SARS-CoV-2 infections pre- and post-SARS-CoV-2 Omicron VOC dominance among infants.

12 Apr 2023

New insights into how Omicron variants avoid destruction by "killer" T cells

Omicron subvariants of SARS-CoV-2 - the virus behind COVID-19 - have shown an uncanny knack for evading antibodies produced either by vaccines or exposure to earlier versions of the virus, leading to many breakthrough infections.

11 Apr 2023

A creative new approach to make vaccine against norovirus

Every year, norovirus causes hundreds of millions of cases of food poisoning - and the deaths of at least 50,000 children - yet there exists no real way to control it.

11 Apr 2023

Novel optical imaging approach provides four-dimensional view of cell secretions

Cell secretions like proteins, antibodies, and neurotransmitters play an essential role in immune response, metabolism, and communication between cells.

11 Apr 2023

Using tiny bubbles to improve gene therapy

Beyond vaccines, mRNA offers immense potential to fight disease, but targeting the genetic material to specific diseased cells is challenging - requiring a new method.

11 Apr 2023

FUJIFILM Irvine Scientific Expands BalanCD CHO Media Platform Portfolio for Bioprocessing

Chemically defined media optimized for growth and productivity of CHO cells in perfusion and batch and fed-batch bioprocesses.

From FUJIFILM Irvine Scientific 11 Apr 2023

Scientists isolate two antibodies that neutralize all current SARS-CoV-2 variants of concern

Researchers found antibodies that neutralize all current SARS-CoV-2 variants.

11 Apr 2023

Antibodies News and Research

How SARS-CoV-2 Omicron subvariants have evolved to evade host T-cell immunity

Antibody response to SARS-CoV-2 is stronger and more durable in infants and young children

Study develops a novel intranasal influenza virus-vectored vaccine for SARS-CoV-2

Study finds no association between maternal SARS-CoV-2 infection and infant neurodevelopment

B cells use mechanical force to pull antigen molecules off other cells

AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice

Using an implantable nanofluidic device to tame pancreatic cancer

MHRA research evaluates two different approaches to cancer therapies

New tool provides insight into the developmental history of certain immune cells

Award-winning project uses INTEGRA pipettes for success in international genetic engineering competition

The virological characteristics of XBB.1.16

The identification of vaccinee-derived antibodies with broad-spectrum Omicron neutralization activity

New organoid platform could make vaccine screening quicker and greatly reduce animal testing

SARS-CoV-2 infection among infants born to maternal COVID-19 cases during Omicron variant predominance

New insights into how Omicron variants avoid destruction by "killer" T cells

A creative new approach to make vaccine against norovirus

Novel optical imaging approach provides four-dimensional view of cell secretions

Using tiny bubbles to improve gene therapy

FUJIFILM Irvine Scientific Expands BalanCD CHO Media Platform Portfolio for Bioprocessing

Scientists isolate two antibodies that neutralize all current SARS-CoV-2 variants of concern

How to make hybridoma-based antibody discovery more efficient eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo